MDT · Medtronic PLC

NYSE Health Care Large Cap Clavix A-
86.38+0.00  (+0.00%)

Price

Snapshot

50 fields · last close
Market Cap$110.5B
P/E21.11
Float1.28B
Beta0.59
Volatility14.8%
ExchangeNYSE
SectorHealth Care
Cap tierLarge cap
Macro sensitivityLow
Clavix score79.9
Price86.38
Change+0.00%
Prev Close86.38
Open86.55
Day Low85.59
Day High87.94
Avg Vol19
Avg $ Vol$1.63B
52W High106.33
52W Low73.31
52W Pos39.6%
From High−18.76%
From Low+17.83%
Max DD 1Y−30.00%
Spread0.10%
LiquidityDeep
SMA 20−4.59%
SMA 50−3.94%
SMA 200−2.56%
RSI (14)35.5
Vol 30D20.2%
Vol 90D28.2%
1Y Range73–106
Daily bars526
Perf Week−2.55%
Perf Month−6.29%
Perf Quarter+4.00%
Perf Half Y−0.29%
Perf Year−8.89%
Perf YTD−10.07%
Prev Day+0.00%
ClavixA-
Debt / Eq0.57
Curr Ratio2.13
Int Cover7.8×
FCF Margin14.9%
Rev Growth+8.4%
ProfitProfitable
LeverageLow
Sector rank16 / 49

What MDT does

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.

It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.

The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products.

The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name.

This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments.

The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors.

Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Clavix risk grade

regraded every trading day
A-79.9/100

MDT grades A-, 79.9 of 100. Steadiest on Macro Resilience (70), most exposed on News Sentiment (54, mixed). 2 of the 4 weighted dimensions sit above the Health Care median. Ranks 16 of 49 in Health Care by Clavix score.

PriceMacroSectorNewsFinancial

How rough the ride is

MDTHealth Care median
Betavs the overall market · lower is steadier0.590.85
Volatilityannualized14.8%21.3%
Max drawdown, past yearworst peak-to-trough fall−30.0%—
Typical daily movemedian absolute daily change0.82%—
Days beyond ±3%of the last 252 sessions15 (6%)—

How its days are spread

Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.

52-week range

MDT
86.38

The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.

Drawdown from the 1-year peak

MDT

Percent below the running high over the last 12 months. Zero is a fresh high.

Market sensitivity

MDTHealth Care median
Beta to the markethow much it swings with the S&P 500 · lower is safer0.590.85
Macro sensitivityrate, dollar and credit exposure bucketLowModerate 53% of 49

Where it sits on the macro scale

Low 12Moderate 26High 8Very High 3

Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.

Where it ranks in its sector

Sector
Health Care49 companies ranked
MDT
#16 of 49

Rank by Clavix score within the sector. Right is the top of the sector.

Price performance

MDT
1 week−2.5%
1 month−6.3%
Year to date−10.1%
1 year−8.9%

Context for the rank, not itself a risk measure.

Recent coverage, scored

MDT
Articles scoredthe most recent scored coverage, up to 3030 since 9 Sep
Average score0 most bearish, 100 most bullish71
Bullish · bearisharticles above 60 · below 4028 · 0
Directionarticles whose tone is improving vs worsening28 ↑ 0 ↓

Where the article scores land

Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.

Balance sheet, against the sector

Debt / equityTotal debt vs shareholder equity · lower is stronger
0.57sector median 0.65 · 49 names
Current ratioShort-term assets vs liabilities · higher is stronger
2.13sector median 1.69 · 49 names
FCF marginFree cash flow as a share of revenue · higher is stronger
14.9%sector median 10.6% · 49 names
Interest coverageOperating income vs interest expense · higher is stronger
7.8×sector median 6.3× · 44 names

The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.

Growth

MDT
Revenue growthyear over year+8.4%

Financial Health is shown but does not count toward the grade. Why

0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.

Recent news

most recent scored articles · the chip is the article’s score · click to open

Medtronic announced that the American Medical Association approved new Category I CPT billing codes for its Altaviva device (treating urge urinary incontinence) and Symplicity Spyral renal denervation system (treating uncontrolled hypertension). The new codes replace existing temporary Category III codes and take effect January 2028.

Source PRNewsWire Significance moderate Impact regulatory Risk improving

Read the article →

Medtronic has received regulatory clearances for new cardiac mapping and ablation software. The approvals come as the company works to compete in the pulsed field ablation market, a newer approach to treating irregular heartbeats that uses short electrical pulses instead of heat or cold.

Source medtechdive.com Significance minor Impact regulatory Risk improving

Read the article →

Medtronic announced it received FDA clearance and a CE Mark (European regulatory approval) for its Affera Prism-2 Mapping Software, and a separate CE Mark for the PulseSelect ProxBox Adapter with Proximity Indicator software, both used in cardiac ablation procedures.

Source PRNewsWire Significance moderate Impact regulatory Risk improving

Read the article →

MDT announced a new magnesium DRT chassis system designed for night hunting, featuring a full-length NV rail with 20-MOA cant, MLOK accessory slots, and an aluminum Arca mounting rail. It retails for $2,249 and is available now for Remington 700 Short Action rifles in black or FDE.

Source thefirearmblog.com Significance minor Impact product Risk improving

Read the article →

Medtronic announced a dividend of $0.72 per share, with the deadline for shareholders to own the stock set for September 25, 2026 and payment due October 16, 2026. The article says it will examine the company's dividend history, yield, growth rates, and whether the payout is sustainable, using data from GuruFocus.

Source yahoo.com Significance moderate Impact financial impact Risk neutral

Read the article →

Nearest peers by size

Health Care
TickerCompanyGradeMkt capP/EBeta
CVSCVS Health CorpA-$110.6B22.610.59Compare
SYKStryker CorpB$105.6B28.330.79Compare
MCKMcKesson CorpB+$105.2B22.910.31Compare
HCAHCA Healthcare IncB+$92.38B13.511.12Compare
ISRGIntuitive Surgical IncB-$138.5B44.111.46Compare
ELVElevance Health IncB+$83.80B16.890.65Compare
ABTAbbott LaboratoriesB+$168.7B31.100.55Compare
CICigna GroupA-$71.48B11.140.26Compare

You just read one holding. Clavix reads the whole portfolio.

Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.